Loading…
Loading…
Figs (FIGS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2026 financial results on Thursday, November 5, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 202.
FIGS Inc. (FIGS) is rated BUY, supported by robust revenue growth, margin expansion, and a debt-free balance sheet enabling aggressive share repurchases. FIGS trades at a 23.8x forward EV/EBITDA premium, justified by A+ growth metrics and consensus EBITDA growth of 35% versus -1% for its closest peer. Recent 2Q26 results saw net revenue up 28.8% YoY, EBITDA margin expand 570 bps, and 70% of revenue driven by repeat customers.
Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
FIGS is driving customer loyalty through innovative scrubs, improved fits and expanded apparel offerings, fueling stronger engagement and revenue growth.
Figs (FIGS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
FIGS, Inc. (NYSE: FIGS - Get Free Report)'s share price reached a new 52-week high during trading on Tuesday. The stock traded as high as $17.98 and last traded at $17.7540, with a volume of 11,302,531 shares changing hands. The stock had previously closed at $15.78. Wall Street Analysts Forecast Growth A number of research firms
Figs broke out above a buy point Monday as the maker of scrubs and other clothing for health care workers has become the No. 1 stock in the entire apparel industry group.